BPMC Oct 2024 95.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 09:32AM EDT. Market open.
| Previous Close | 19.90 |
| Open | 19.90 |
| Bid | 17.00 |
| Ask | 21.70 |
| Strike | 95.00 |
| Expire Date | 2024-10-18 |
| Day's Range | 19.90 - 19.90 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
GuruFocus.comInsider Sale: Chief Scientific Officer Percy Carter Sells Shares of Blueprint Medicines Corp (BPMC)
On June 5, 2024, Percy Carter, Chief Scientific Officer of Blueprint Medicines Corp (NASDAQ:BPMC), sold 4,000 shares of the company.
GuruFocus.comInsider Sale at Blueprint Medicines Corp (BPMC): Chief Medical Officer L. Hewes Sells Shares
On June 4, 2024, L. Hewes, Chief Medical Officer of Blueprint Medicines Corp (NASDAQ:BPMC), sold 2,424 shares of the company.
PR NewswireBlueprint Medicines Announces Data Presentations at EAACI and EHA Annual Meetings Highlighting Sustained Clinical Benefits of AYVAKIT®/AYVAKYT® (avapritinib)
Blueprint Medicines Corporation (Nasdaq: BPMC) today announced multiple upcoming datasets across two key conferences that reinforce the significant real-world burden of systemic mastocytosis (SM), and highlight the durable clinical outcomes of AYVAKIT®/AYVAKYT® (avapritinib) across the spectrum of the disease. The presentations, which build on over a decade of pioneering research with clinical experts and patient advocates, will be reported at the following meetings:
© 2024 Yahoo. All rights reserved.